Bonwrx, Ltd.
Country not established FDA FEI 3004099322
- Devices
- 1
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA FEI
What Bonwrx, Ltd. makes
Bonwrx, Ltd. manufactures the VK100 Percutaneous Vertebral Augmentation System, a device used for minimally invasive spinal stabilization by injecting bone cement into fractured vertebrae to restore structural integrity.
The VK100 is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) premarket notification process. The company is based in the United States.
Catalogue
VK100 Percutaneous Vertebral Augmentation System Ref K192403
510(k) 510(k)
Company details
- FDA FEI number
- 3004099322
- Address
- 924 TERMINAL RD, Lansing, MI, 48906
Frequently asked questions
How many devices does Bonwrx, Ltd. have in the registry?
The registry currently lists 1 device for Bonwrx, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Bonwrx, Ltd.'s devices?
Among its 1 most recently registered device, Bonwrx, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Bonwrx, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Bonwrx, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Bonwrx, Ltd. in the registry?
The most recently registered devices listed for Bonwrx, Ltd. include VK100 Percutaneous Vertebral Augmentation System.